IP Library Granted Patent US 8,114,986
Granted Patent B2
US 8,114,986 · App. 11/989,054 · Granted Feb 14, 2012

Analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,986
App. No.
11/989,054
Granted
Feb 14, 2012
Kind
B2
Abstract

The invention relates to analogous compounds of 6-thioguanosine triphosphate of general formula (I). A compound of the general formula (I); wherein the dashed bond in the sugar moiety can be either single or double and wherein R1, R2, R3, R4 or R5, equal or different between each other, have general formula -(Int) m -Ter, wherein m is between 0 and 12 and Int and Ter are Internal and Terminal building blocks, wherein Int is selected from the group consisting of formula (II); and Ter is selected from the group consisting of formula (III). And wherein X represents either carbon or nitrogen atom within aromatic ring, Y represents either oxygen or sulphur atom and an additional group Q, group Qi or groups Qi (Qi indicates that the group or several groups may be bound to any unsaturated moiety of the ring) are selected from the group consisting of —OH, —COOH, —N(CH 3 ) 2 , —N(CH 2 —CH 3 ) 2 |—CO—CH 3 , —CO—O—CH 3 , —O—CH 3 , —S—CH 3 , —SO 2 —CH 3 , —CN, —NO 2 or -Halogen elements, and wherein R5 may be formula (IV) and metal and ammonium salts thereof, wherein n is between O and 5, or oxygen or phosphorus is partially or completely replaced by nitrogen, sulphur, methyleno groups or their derivatives. The invention also concerns the uses of the above mentioned compounds in medical field and the process for their preparation.

Claims (14)

1. A compound of the general formula (II):

wherein the dashed line indicates that the —O—CO—NH-Int m -Ter moiety is at either the 3′ or 2′ position and an —OH is at the other; and

wherein n=0, 1, 2 or 3, m is between 0 and 5, Int is selected from the group consisting of

and Ter is selected from group the consisting of

wherein X represents either carbon or nitrogen atom within aromatic ring, Y represents either oxygen or sulphur atom and an additional group Q or groups Qi are selected from the group consisting of —CH 3 , —C(CH 3 ) 3 , —OH, —COOH, —CO—CH 3 , —CO—O—CH 3 , —O—CH 3 , —S—CH 3 , —SO 2 —CH 3 , —N(CH 3 ) 2 , —N(CH 2 —CH 3 ) 2 , —CN, —NO 2 or -halogen and wherein Qi indicates that the group or several groups may be bound to any unsaturated moiety of the ring.

2. A compound as claimed in claim 1 with the following structure:

3. A compound as claimed in claim 1 wherein n is 0.

4. A compound as claimed in claim 1 wherein n is 3.

5. A compound as claimed in claim 1 wherein n is 1.

6. A compound as claimed in claim 1 wherein n is 2.

7. The compound of claim 1 , wherein Int is —CH 2 —.

8. The compound of claim 7 , wherein Ter is —NH 2 .

9. A compound represented by:

10. A compound represented by:

Assignments (1)
CHANGE OF NAME Recorded Nov 14, 2012
From: GIULIANI INTERNATIONAL LIMITED
To: NOGRA PHARMA LIMITED
Reel/Frame 029295/0861 →